Humacyte, a bioengineering company, went public through a SPAC merger in 2015, with a market value of $1.1 billion. The company has received FDA's RMAT designation for three indications, including ...
Paul Stankey (left) is a fourth-year PhD student at Harvard School of Engineering and Applied Sciences and the Wyss Institute (both MA, USA), working in Professor Jennifer Lewis’ lab. Jennifer leads a ...
Hosted on MSN
A breakthrough in bioprinting may soon lead to 3D-printed blood vessels and human organs
A breakthrough in bioprinting of living tissues could soon lead to 3D-printing of blood vessels and human organs, ushering in a new era of regenerative medicine. Guohao Dai, a bioengineering professor ...
Precise Bio 3D printed a cornea implant from living human cells, and the Rambam Health Care Campus successfully transplanted ...
Women recovering from mastectomies may soon have more lifelike options for breast reconstruction surgery, thanks to 3D-printing technology under development at the University of Maryland, College Park ...
Engineers at the University of Pittsburgh are working to develop 3D-printed organic tissue models that mimic the behavior of living organs. Online cover of Science Advances, April issue. A ...
Researchers at the Institute for Bioengineering of Catalonia (IBEC) in collaboration with the Dexeus University Hospital have captured unparalleled images of a human embryo implanting. This is the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback